Archive: 31/05/2019

40-50% response rate for brigatinib after other next-gen ALK inhibitors

Crizotinib was the first drug licensed to treat ALK-positive non-small cell lung cancer (ALK+ NSCLC). Since then, a range of next-generation ALK-inhibitors including ceritinib, alectinib, and brigatinib have earned FDA approval ...

May 31, 2019

0

36

Research deepens understanding of gut bacteria's connections to human health, disease

Researchers at Oregon State University have made an important advance in understanding the roles that gut bacteria play in human health.

May 31, 2019

0

1257

Health progress threatened by neglect of gender

The Sustainable Development Goals offer the prospect of ensuring healthy lives for the world's population by 2030. But this ambition will not be realised without eliminating gender inequality and changing society's attitudes ...

May 31, 2019

Changes to immune genes link paternal smoking with childhood asthma

Children exposed to paternal tobacco smoking before birth are more likely to develop asthma—and associated changes to immune genes predict the level of risk.

May 31, 2019

0

164

Clinical calculator could spare breast cancer patients five years of unnecessary hormone therapy

New research confirms that an algorithm, called CTS5, can accurately identify patients who are at a significantly low risk of their breast cancer returning at a later stage. In doing so it means some patients may need to ...

May 31, 2019

page 8 from 8

«
»